T&R Biofab Co., Ltd. (KOSDAQ: 246710)

Market Cap	126.05B
Revenue (ttm)	4.94B
Net Income (ttm)	-14.37B
Shares Out	21.55M
EPS (ttm)	-671.96
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,676
Open	5,970.00
Previous Close	5,960.00
Day's Range	5,850.00 - 6,080.00
52-Week Range	5,190.00 - 13,890.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About T&R Biofab

T&R Biofab Co., Ltd. engages in the research and development of medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. It offers craniomaxillofacial meshes, dental meshes, and patient specific implants; and bioinks for 3D bioprinting and cell culture, stem cell research and delivery, and coating of scaffold and cultural dishes. The company was founded in 2013 and is based in Siheung-si, South Korea.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 246710

Financial Performance

In 2023, T&R Biofab's revenue was 5.20 billion, a decrease of -9.65% compared to the previous year's 5.75 billion. Losses were -13.42 billion, 29.8% more than in 2022.